Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
| Episode | Date |
|---|---|
|
E101: Antipsychotics: D2 and 5HT2A Receptor Activity
|
Oct 28, 2026 |
|
E100: Antipsychotics: Dosing
|
Oct 21, 2026 |
|
E99: Antipsychotics: Introduction
|
Oct 14, 2026 |
|
E98: Antipsychotics: Medical Work-up for Psychosis
|
Oct 07, 2026 |
|
E97: Antipsychotics: Schizophrenia: Psychogenic Polydipsia and Catatonia
|
Sep 30, 2026 |
|
E96: Antipsychotics: Schizophrenia Diagnosis and Pathophysiology
|
Sep 23, 2026 |
|
E95: Antipsychotics: Schizophrenia Background Information
|
Sep 17, 2026 |
|
E94: Obesity Medicine: Weight Loss Procedures, Lipedema, and MASLD
|
Sep 13, 2026 |
|
E93: Obesity Medicine: GLP1s of the Future, Weight Loss Meds for Kids, and the Insurance Gauntlet
|
Aug 02, 2026 |
|
E92: Obesity Medicine: GLP-1s: Saxenda, Wegovy, Zepbound, and Foundayo
|
Jul 20, 2026 |
|
E91: Obesity Medicine: GLP-1s: Eating Disorders, Drug Interactions, Shortages, Cost, and Compounding
|
Jul 14, 2026 |
|
E90: Obesity Medicine: GLP-1 Contraindications, Adverse Effects, and What To Do About It
|
Jul 04, 2026 |
|
E89: Obesity Medicine: GLP-1 Dosing and Duration of Use
|
Jun 17, 2026 |
|
E88 Obesity Medicine: GLP-1 Introduction, Mechanism, and Benefits
|
Jun 07, 2026 |
|
E87 Obesity Medicine: Medication: Other Medications
|
May 27, 2026 |
|
E86 ADHD: Effects of Menstrual Cycle and Perimenopause and Harder to Treat ADHD
|
May 20, 2026 |
|
E85: Obesity Medicine: Medication: Phentermine/Topiramate ER (Qsymia) and Naltrexone/Bupropion (Contrave)
|
May 13, 2026 |
|
E84: ADHD: Non-Stimulants Part 2: Guanfacine (Intuniv), Clonidine (Kapvay, Onyda XR), TCAs, Bupropion, Solriamfetol, Centanafadine, and Saffron
|
May 04, 2026 |
|
E83: Obesity Medicine: Medication: Phentermine, Vyvanse, and More Stimulants
|
Apr 08, 2026 |
|
E82: ADHD: Non-Stimulants Part 1: Atomoxetine (Strattera) and Viloxazine (Qelbree)
|
Apr 02, 2026 |
|
E81: Obesity Medicine: Medical Assessment Before Starting Obesity Medications
|
Mar 25, 2026 |
|
E80: Obesity Medicine: Lifestyle Medicine: Sleep, Toxins, Social, Learning, and the Outdoors
|
Mar 17, 2026 |
|
E79: ADHD: Stimulants: Adverse (Side) Effects Part 3: Substance Abuse Risk
|
Mar 06, 2026 |
|
E33: Antidepressant Efficacy Part 3: The Case for Antidepressants
|
Mar 04, 2026 |
|
E31: Psychogenomic Testing (RePublish for Spotify)
|
Mar 04, 2026 |
|
E30: Improving Efficacy of Medications (RePublish for Spotify)
|
Mar 04, 2026 |
|
E29: Efficacy of Antidepressants (RePublish for Spotify)
|
Mar 04, 2026 |
|
E78: Obesity Medicine: Lifestyle Medicine: Physical Fitness
|
Mar 01, 2026 |
|
Quick Take #8: February Updates!: New Ketogenic Diet Studies for Mental Health Disorders, ProlivRX for Depression, New Blood Test for Alzheimers, and MORE!!!
|
Feb 18, 2026 |
|
E77: ADHD: Stimulants: Adverse (Side) Effects Part 2: Cardiac and Pregnancy
|
Feb 11, 2026 |
|
E76 Obesity Medicine: How Deception Works, How I've Been Deceived, and Corrections I'm Making
|
Feb 04, 2026 |
|
QT7: Quick Take #7: Why Is Adderall A Mixture of Salts?
|
Jan 28, 2026 |
|
E75: ADHD: Stimulants: Adverse (Side) Effects
|
Jan 21, 2026 |
|
E74 Obesity Medicine: Lifestyle Medicine: Barriers to Healthy Eating
|
Jan 14, 2026 |
|
E73 ADHD: Stimulants: Methylphenidate: Adhansia XR, Focalin, Azstarys, Modafinil (Provigil), and Armodafinil (Nuvigil)
|
Jan 07, 2026 |
|
E72 Obesity Medicine: Lifestyle Medicine: Scientific Evidence for Diet Improving Mood
|
Dec 31, 2025 |
|
Quick Take #6: Nov 25 Updates! Part 2: Seltorexant, Fecal Transplant, and Ketogenic Diet for Depression? LSD for Anxiety? Vomiting in Pregnancy Associated with Depression? And More!!!
|
Dec 28, 2025 |
|
E71 :ADHD: Stimulants: Methylphenidate: Daytrana, Quillavant XR, Quillachew XR, Aptensio XR, Cotempla ODT-XR, and Jornay PM
|
Dec 24, 2025 |
|
E70: Obesity Medicine: Lifestyle Medicine: Cholesterol, Protein, and Healthy Foods for your Brain
|
Dec 17, 2025 |
|
Quick Take #5: Nov 25 Updates! Part 1: Guanfacine for Catatonia? Doxycycline for Schizophrenia? More Data on Pramipexole for Depression? Is Vortioxetine Anti-inflammatory? And More!!!
|
Dec 13, 2025 |
|
E69 ADHD: Stimulants: Methylphenidate: Ritalin, Methylin, Metadate, and Concerta
|
Dec 10, 2025 |
|
E68: Obesity Medicine: Lifestyle Medicine: Fats: Saturated Fats and Seed Oils
|
Dec 03, 2025 |
|
E67: ADHD: Stimulants: Lisdexamfetamine (Vyvanse) and Amphetamine Base Medications
|
Nov 26, 2025 |
|
E66: Obesity Medicine: Lifestyle Medicine: Fructose and Artificial Sweeteners
|
Nov 19, 2025 |
|
E65 ADHD: Stimulants: Dextroamphetamine and Mixed Amphetamine Salts (Adderall)
|
Nov 12, 2025 |
|
E64: Obesity Medicine: Lifestyle Medicine: Ultra-Processed Foods
|
Nov 05, 2025 |
|
E63: ADHD: Introduction to Stimulants
|
Oct 29, 2025 |
|
E62: Obesity Medicine: Lifestyle Medicine: Ketogenic Diet
|
Oct 22, 2025 |
|
E61: ADHD: Medication Aspects to Consider
|
Oct 15, 2025 |
|
E60: Obesity Medicine: Lifestyle Medicine: Nutrition Recommendations
|
Oct 08, 2025 |
|
E59: ADHD: Treatments Other Than Medications
|
Oct 01, 2025 |
|
E58: Obesity Medicine: Lifestyle Medicine: Nutrition Introduction
|
Sep 24, 2025 |
|
Quick Take #4: Sept 25 Updates! Part Deux: Benefits of Drug Treatment of ADHD, ChatGPT-induced Bromide Poisoning Psychosis, Ineffectiveness of Gabapentin, Newest GLP-1 Trial Results, and MORE!!!
|
Sep 20, 2025 |
|
E57: ADHD: Adult ADHD
|
Sep 17, 2025 |
|
Quick Take #3: Sept 25 Updates! Part 1: Old Drugs For New Indications (Ketamine, Strattera, Flexeril) And Some Antidepressants On The Horizon (Nelivaptan and Seltorexant)
|
Sep 13, 2025 |
|
E56: Obesity Medicine: Medical Effects of Obesity and Assessing the Obese Patient
|
Sep 10, 2025 |
|
E55: ADHD: Diagnosis, Comorbidities, and Differential
|
Sep 05, 2025 |
|
E54: Obesity Medicine: Measurements, Rates, Trends, and Causes
|
Aug 27, 2025 |
|
E53: Attention Deficit Hyperactivity Disorder (ADHD): Background and Pathophysiology
|
Aug 20, 2025 |
|
E52: Depression Differential: When to Consider Bipolar Disorder or Something Else
|
Aug 13, 2025 |
|
E51: Procedures: Bright Light Therapy, Vagal Nerve Stimulation, Transcranial Magnetic Stimulation, Cranial Electrotherapy Stimulators
|
Aug 06, 2025 |
|
E50: Electroconvulsive Therapy: The Most Effective Psychiatric Treatment
|
Jul 30, 2025 |
|
Quick Take #2: Jul 25 Updates!: FDA Denies New Treatment for PTSD, Alcohol Intake Limit Recommendation Ends?, New BBW on SSRIs?, Clozapine REMS Ends!, New Psychedelic for Depression?, and Many More!
|
Jul 26, 2025 |
|
E49: NAC, Creatine, Aromatherapy, Unfounded Alternative Treatments, and Complementary Medicine Wrap-Up
|
Jul 23, 2025 |
|
E48: Omega-3 Fatty Acids: Are They Good For Mental Health, Too?
|
Jul 16, 2025 |
|
E47: Zinc: The Second Most Important Mineral for Mental Health?
|
Jul 09, 2025 |
|
E46: Magnesium: The Most Important Mineral for Mental Health?
|
Jul 02, 2025 |
|
E45: Vitamin D: Does Supplementation Help With Mental Health?
|
Jun 25, 2025 |
|
E44: L-Methylfolate (Deplin) and SAMe for the Treatment of Depression
|
Jun 18, 2025 |
|
E43: B Vitamins and Why They Are Important for Mental Health
|
Jun 11, 2025 |
|
Quick Take #1: Suzetrigine (Journavx)
|
Jun 06, 2025 |
|
E42: Herbal Antidepressants: St. John's Wort, Rholiola Rosea, and Kanna
|
Jun 04, 2025 |
|
E32: UPDATE! Medication Treatment Course: Discontinuation and Taper of Antidepressants
|
Jun 03, 2025 |
|
E41: Hypogonadism vs Depression
|
May 28, 2025 |
|
E40: UPDATE! Breastfeeding and Antidepressant Safety: L1-L5 Updates
|
May 25, 2025 |
|
E40: Breastfeeding and Antdepressant Safety
|
May 21, 2025 |
|
E39: Peri-partum Depression: Including Antidepressant use, Brexanolone (Zulresso), and Zuranolone (Zurzuvae)
|
May 14, 2025 |
|
E38: Premenstrual Dysphoric Disorder (PMDD) and Peri-menopausal Psychiatric Symptom Treatments: Estrogen, Progestin, Testosterone, Duavee, Veozah, Tamoxifen
|
May 07, 2025 |
|
E37: Pediatric and Geriatric Psychiatric Drug Management
|
Apr 30, 2025 |
|
E36: Depression Subtypes: How to Pick the Best Antidepressant for Each
|
Apr 22, 2025 |
|
E35: Antidepressant Augmentation
|
Apr 16, 2025 |
|
E34: Antidepressant Switching
|
Apr 10, 2025 |
|
E21: NDRI: Bupropion (Wellbutrin) (RePublish)
|
Apr 08, 2025 |
|
E20: SARIs: Trazodone and Nefazodone (RePublish)
|
Apr 07, 2025 |
|
E33: Antidepressant Efficacy Part 3: The Case for Antidepressants
|
Apr 02, 2025 |
|
E32: Medication Treatment Course
|
Mar 26, 2025 |
|
E31: Psychogenomic Testing
|
Mar 19, 2025 |
|
E30: Improving Efficacy of Medications
|
Mar 12, 2025 |
|
E29: Efficacy of Antidepressants
|
Mar 05, 2025 |
|
E28: Selecting an Antidepressant
|
Feb 26, 2025 |
|
E27: Investigational Antidepressants
|
Feb 19, 2025 |
|
E26: Antidepressant Dosing
|
Feb 12, 2025 |
|
E25: 5-HT1A Partial Agonist: Gepirone ER (Exxua)
|
Feb 05, 2025 |
|
E24: NMDA Receptor Antagonists: Ketamine, Esketamine (Spravato), and Dextromethorphan+Bupropion (Auvelity)
|
Jan 30, 2025 |
|
E23: Serotonergic Modulators and Stimulators: Vilazodone and Vortioxetine (Viibryd and Trintellix)
|
Jan 22, 2025 |
|
E22: Noradrenergic and Specific Serotonergic Antidepressant: Mirtazapine (Remeron)
|
Jan 14, 2025 |
|
E21: NDRI: Bupropion (Wellbutrin)
|
Jan 07, 2025 |
|
E20: Serotonin Antagonist and Reuptake Inhibitors (SARIs): Trazodone and Nefazodone
|
Dec 28, 2024 |
|
E19: SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors): Venlafaxine, Duloxetine, Desvenlafaxine, Milnacipran, Levomilnacipran
|
Dec 18, 2024 |
|
E18: SNRI Overview
|
Dec 11, 2024 |
|
E17: SSRIs (Selective Serotonin Reuptake Inhibitors): Fluoxetine, Sertraline, Paroxetine, Fluvoxamine, Citalopram, Escitalopram
|
Dec 04, 2024 |
|
E16: SSRI Overview
|
Nov 28, 2024 |
|
E15: Serotonergic Adverse Effects
|
Nov 20, 2024 |
|
E14: Serotonin Toxicity (AKA Syndrome)
|
Nov 14, 2024 |
|
E13: Antidepressants and Suicide Risk
|
Nov 08, 2024 |
|
Episode 12: PDE5 inhibitors and Supplements for Sexual Dysfunction
|
Oct 29, 2024 |
|
Episode 11: Sexual Dysfunction Associated with Serotonergic Medications
|
Oct 28, 2024 |
|
Episode 10: QTc Prolongation
|
Oct 23, 2024 |
|
Episode 9: Receptor Selective (2nd Generation) Antidepressants
|
Oct 23, 2024 |
|
Trailer
|
Oct 13, 2024 |
|
Episode 8: Tricyclic Antidepressants
|
Oct 12, 2024 |
|
Episode 7: Neuroreceptors
|
Oct 12, 2024 |
|
Episode 6: Monoamine Oxidase Inhibitors (MAOIs)
|
Oct 12, 2024 |
|
Episode 5: Introduction to Antidepressants
|
Oct 12, 2024 |
|
Episode 4: Depression Treatment Overview
|
Oct 12, 2024 |
|
Episode 3: Introduction to Depression Part 2
|
Oct 12, 2024 |
|
Episode 2: Introduction to Depression Part 1
|
Oct 12, 2024 |
|
Episode 1: Introduction to This Is Your Brain on Drugs Psychiatry Podcast
|
Sep 19, 2024 |